Targeted degradation of CD24 by a transferrin receptor-engaging bispecific degrader enhances antitumor immunityMaorong Zhu, Xiao Liu, Cheng Zou et al.|Biochemical Pharmacology|2026Cited by 1
Targeting TRIM25 as a therapeutic strategy to enhance ferroptosis in glioblastoma cellsMaorong Zhu, Zhengcong Cao, Yuxin Wu et al.|Journal of Nanobiotechnology|2026Cited by 0
Current Status and Evolution of Immunotherapy in Glioma ManagementJiaying Liu, Jintao Gu, Guangzhao Yang et al.|International Journal of Medical Sciences|2026Cited by 0